(Q33539608)

27 July 2017

1 reference

title

Use of nasal steroids in managing allergic rhinitis (English)

1 reference

27 July 2017

1 reference

LaForce C

1

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

The Journal of Allergy and Clinical Immunology

27 July 2017

published in

1 reference

27 July 2017

volume

103

1 reference

27 July 2017

issue

3 Pt 2

1 reference

27 July 2017

page(s)

S388-94

1 reference

The clinical efficacy of budesonide in hay fever treatment is dependent on topical nasal application

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Fluticasone propionate: topical or systemic effects?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Molecular mechanisms of steroid action in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

The mechanisms of antiinflammatory steroid action in allergic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Mode of action of corticosteroids in asthma and rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Anti-inflammatory actions of steroids: molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Quantitative intranasal pollen challenge. II. Effect of daily pollen challenge, environmental pollen exposure, and placebo challenge on the nasal membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Observations on the pathogenesis of nasal priming

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Activation of guinea pig lymphocytes and mast cells by grain-dust extract

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Antiinflammatory steroids inhibit granulocyte/macrophage colony-stimulating factor production by human lung tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Effect of topical corticosteroids on seasonally induced increases in nasal mast cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

A comparative trial of intra-nasal beclomethasone dipropionate and sodium cromoglycate in patients with chronic perennial rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Comparison of intranasal triamcinolone acetonide with oral loratadine for the treatment of patients with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

The effect of beclomethasone dipropionate aerosol on allergen induced nasal stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Effects of beclomethasone dipropionate nasal spray on subjective and objective findings in perennial allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Budesonide and nasal allergen challenge testing in man

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Topical glucocorticosteroids and allergen-induced increase in nasal reactivity: relationship between treatment time and inhibitory effect

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Early and late nasal symptom response to allergen challenge. The effect of pretreatment with a glucocorticosteroid spray.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Interleukin-5 and eosinophil cationic protein in nasal lavages of rhinitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Effect of topical applications of budesonide and azelastine on nasal symptoms, eosinophil count and mediator release in atopic patients after nasal allergen challenge during the pollen season

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Allergic rhinitis and inflammation: the effect of nasal corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Effect of 3 months' nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

An intranasal glucocorticoid inhibits the increase of specific IgE initiated during birch pollen season

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Delayed hypersensitivity reactions to corticosteroids applied to mucous membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Long-term treatment of nasal polyps with beclomethasone dipropionate aerosol. III. Morphological studies and conclusions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Intranasal fluocortin butyl in patients with perennial rhinitis: a 12-month efficacy and safety study including nasal biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

New formulation of aqueous flunisolide nasal spray in the treatment of allergic rhinitis: comparative assessment of safety, tolerability, and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Adrenal function during the use of dexamethasone aerosols in the treatment of ragweed hay fever

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Triamcinolone acetonide. A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Posterior subcapsular cataracts associated with nasal or inhalation corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Onset of action of aqueous beclomethasone dipropionate nasal spray in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Aqueous beclomethasone diproprionate nasal spray: regular versus "as required" use in the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Aqueous beclomethasone dipropionate in the treatment of ragweed pollen-induced rhinitis: further exploration of "as needed" use.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Nasal mucosal inflammation has no effect on the absorption of intranasal triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Flunisolide metabolism and dynamics of a metabolite

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Nasal bioavailability and systemic effects of the glucocorticoid budesonide in man

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970218-6

7 January 2021

10.1016/S0091-6749(99)70218-6

Identifiers

DOI

1 reference

27 July 2017

1 reference